Skip to content

BIOXYTRAN, INC.

BIXT

CIK 0001445815

← back to feed
Revenue (TTM)
$80.53K
−22.5% YoY Q1 May 2026
Net Income (TTM)
−$3.67M
+10.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.04
0.0% YoY Q1 May 2026
Gross Margin
137.1%
Q1 May 2026
Operating Margin
-3,934.1%
Q1 May 2026
Net Margin
-4,557.0%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$23.45K
Q1 May 2026
Total Debt
$48.07K
Q1 May 2026
Shares Outstanding
114.2M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings